<DOC>
	<DOCNO>NCT01064557</DOCNO>
	<brief_summary>The main purpose AIDA protocol test role intermittent maintenance therapy ATRA , standard maintenance chemotherapy methotrexate 6-mercaptopurine PCR negative patient end consolidation phase evaluate role allogeneic autologous bone marrow transplantation PCR positive patient end consolidation phase .</brief_summary>
	<brief_title>`` AIDA '' Protocol ( LAP 0493 )</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Tretinoin</mesh_term>
	<criteria>Age &gt; 12 month ( 1 year ) &lt; 75 year Morphological newly diagnosis APL Presence PMLRARa transcript No cardiac contraindication anthracycline chemotherapy Serum creatinine &lt; =2.5 mg/dL Serum alkaline phosphatase &lt; = 3 time normal upper limit Serum bilirubin &lt; = 3 time normal upper limit Serum SGOT &lt; = 3 time upper normal limit Negative pregnancy test Informed consent Age &lt; = 12 month &gt; =75 year absence PMLRARa transcript Pregnant lactate woman Presence active serious infection control antibiotic Prior treatment antileukemic therapy ( excluded corticosteroid ) Presence severe concomitant psychiatric disease Presence concomitant malignant tumor , except basal cell carcinoma Concurrent treatment cytotoxic chemotherapy radiotherapy Cardiac contraindication anthracycline chemotherapy Serum creatinine &gt; 2.5 mg/dL Serum alkaline phosphatase &gt; 3 time normal upper limit Serum bilirubin &gt; 3 time normal upper limit Serum SGOT &gt; 3 time upper normal limit Positive pregnancy test Absence inform consent</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Acute promyelocytic Leukemia</keyword>
</DOC>